`Date: January 28, 2016
`
`
`
`
`
`
`
`
`Trials@uspto.gov
`571-272-7822
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_____________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`ENDOLOGIX, INC.
`Petitioner,
`
`v.
`
`LIFEPORT SCIENCES LLC,
`Patent Owner.
`____________
`
`Case IPR2015-01722
`Patent 8,192,482 B2
`____________
`
`
`Before JOSIAH C. COCKS, JAMES B. ARPIN, and
`MICHAEL L. WOODS, Administrative Patent Judges.
`
`COCKS, Administrative Patent Judge.
`
`ORDER
`Conduct of Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`
`
`IPR2015-01722
`Patent 8,192,482 B2
`
`
`
`In its Petition for inter partes review (Paper 1, “Pet.”), Petitioner,
`
`
`
`Endologix, Inc., asserts that U.S. Patent No. 8,192,482 (“the ’482 patent”)
`
`expired on September 27, 2014. Pet. 19. Patent Owner, Lifeport Sciences
`
`LLC, filed no Preliminary Response and has set forth no position regarding
`
`the expiration date of the ’482 patent. The applicable claim construction
`
`standard may turn, at least in part, on the expiration date of the ’482 patent.
`
`Accordingly, it is
`
`ORDERED that, pursuant to 37 C.F.R. § 42.5, Patent Owner shall file
`
`a notice no later than February 2, 2016 that sets forth whether Patent Owner
`
`represents that the ’482 patent has expired, and, if so, the date on which the
`
`’482 patent expired.
`
`2
`
`
`
`
`
`
`
`
`IPR2015-01722
`Patent 8,192,482 B2
`
`For PETITIONER:
`
`Sanjay Murthy
`sanjay.murthy.ptab@klgates.com
`
`
`
`For PATENT OWNER:
`
`Robert Ashbrook
`robert.ashbrook@dechert.com
`
`Kevin Flannery
`kevin.flannery@dechert.com
`
`
`
`3